title: Juxtapapillary neovascular membrane secondary to idiopathic intracranial hypertension treated with intravitreal bevacizumab: A case report.
abstract: METHODS
  A 48 year-old woman with visual acuity loss in left eye (0.3). Funduscopic examination showed papillary oedema and neovascular membrane in the left eye. All neurological tests were normal, except the lumbar puncture with opening pressure of 35cmH2O, being diagnosed with idiopathic intracranial hypertension (IIH). After four doses of bevacizumab, the visual acuity of the left eye has not improved and is counting fingers.
  
  
  CONCLUSIONS
  Pathogenesis of the juxtapapillary neovascular membrane associated with IIH is not well known. An effect was observed after the anti-VEGF treatment. In our case, there was no improvement after four doses of intravitreal bevacizumab.
authors.affiliation: Servicio de Oftalmología, Hospital Virgen de la Salud, Toledo, España. Electronic address: vhernandezortega@gmail.com.
authors.forename: V
authors.initials: V
authors.lastname: Hernández-Ortega
authors.affiliation: Servicio de Oftalmología, Hospital Virgen de la Salud, Toledo, España.
authors.forename: M I
authors.initials: MI
authors.lastname: Soler-Sanchís
authors.affiliation: Servicio de Oftalmología, Hospital Virgen de la Salud, Toledo, España.
authors.forename: R M
authors.initials: RM
authors.lastname: Jiménez-Escribano
authors.affiliation: Servicio de Oftalmología, Hospital Virgen de la Salud, Toledo, España.
authors.forename: A M
authors.initials: AM
authors.lastname: Sanz-López
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011559:Pseudotumor Cerebri / Q000150:complications* / Q000188:drug therapy*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor
keywords: Agudeza visual; Bevacizumab intravítreo; Hipertensión intracraneal idiopática; Idiopathic intracranial hypertension; Intrtravitreal bevacizumab; Macula; Membrana neovascular; Mácula; Neovascular membrane; Visual acuity